只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-15 2026-07-15 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,500 | US$0.86 | US$1,290.00 | 368,385 | SEC |
| 2026-07-14 2026-07-15 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 2,800 | US$0.88 | US$2,464.00 | 366,885 | SEC |
| 2026-07-10 2026-07-10 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,000 | US$0.94 | US$940.00 | 369,485 | SEC |
| 2026-07-09 2026-07-10 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,000 | US$0.90 | US$900.00 | 368,485 | SEC |
| 2026-07-08 2026-07-10 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,500 | US$0.97 | US$5,335.00 | 367,485 | SEC |
| 2026-07-08 2026-07-08 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,400 | US$0.96 | US$5,208.30 | 361,985 | SEC |
| 2026-06-18 2026-06-22 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 800 | US$0.96 | US$768.00 | 300,566 | SEC |
| 2026-06-17 2026-06-22 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,500 | US$0.85 | US$1,275.00 | 299,766 | SEC |
| 2026-06-10 2026-06-11 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Altmeyer Anne Director | 卖出（S） | 2,412 | US$7.91 | US$19,078.92 | 7,579 | SEC |
| 2026-06-09 2026-06-09 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,000 | US$0.85 | US$4,250.00 | 298,266 | SEC |
| 2026-06-04 2026-06-05 | ADNT Adient plc | Tiltmann Heather M Officer · EVP, CLO, CHRO & Secretary | 卖出（S） | 22,000 | US$22.71 | US$499,620.00 | 110,886.22 | SEC |
| 2026-05-20 2026-05-21 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,500 | US$0.92 | US$1,380.00 | 293,266 | SEC |
| 2026-05-19 2026-05-21 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 200 | US$0.95 | US$190.00 | 291,766 | SEC |
| 2026-05-18 2026-05-18 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,700 | US$0.92 | US$5,244.00 | 291,566 | SEC |
| 2026-05-15 2026-05-15 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,100 | US$1.02 | US$5,202.00 | 285,866 | SEC |
| 2026-05-13 2026-05-15 | HLIT HARMONIC INC. | Haltmayer Neven Officer · SVP & GM, Video Business | 卖出（S） | 31,766 | US$13.24 | US$420,581.84 | 133,924 | SEC |
| 2026-05-01 2026-05-05 | EME EMCOR Group, Inc. | Altmeyer John W Director | 卖出（S） | 2,500 | US$895.00 | US$223.75万 | 33,616 | SEC |
| 2026-04-29 2026-04-29 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,000 | US$1.11 | US$5,550.00 | 280,766 | SEC |
| 2026-04-23 2026-04-24 | WSBC WESBANCO INC | Altman Louis Michael Director | 买入（P） | 3,000 | US$33.72 | US$101,160.00 | 33,164.29 | SEC |
| 2026-04-21 2026-04-22 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 400 | US$1.23 | US$492.00 | 275,766 | SEC |
| 2026-04-20 2026-04-22 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 600 | US$1.23 | US$738.00 | 275,366 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| PLTM | 38,136.4332 | 0 | 53,857.9973 | 70.81% | Q, N |
| LTM | 73,346.175 | 1 | 149,793.2053 | 48.96% | B, Q, N |